Altered Expression of Human Mitochondrial Branched Chain Aminotransferase in Dementia with Lewy Bodies and Vascular Dementia

Neurochemical Research

Volumn 42, Issue 1, 2017, Pages 306-319

  Ashby, Emma L ^a   Kierzkowska, Marta ^a   Hull, Jonathon ^a   Kehoe, Patrick G ^b   Hutson, Susan M ^c   Conway, Myra E ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

Alzheimer s disease; Branched chain aminotransferase; Dementia with Lewy body; Glutamate; hBCATc; hBCATm; Vascular dementia

Indexed keywords

AMINOTRANSFERASE; CYTOSOLIC HUMAN BRANCHED CHAIN AMINOTRANSFERASE; MITOCHONDRIAL HUMAN BRANCHED CHAIN AMINOTRANSFERASE; UNCLASSIFIED DRUG; BCAT1 PROTEIN, HUMAN; BCAT2 PROTEIN, HUMAN; BRANCHED-CHAIN-AMINO-ACID TRANSAMINASE; MINOR HISTOCOMPATIBILITY ANTIGEN; PLACENTA PROTEIN;

AGED; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DENTATE HILUS; DIFFUSE LEWY BODY DISEASE; FEMALE; FRONTAL CORTEX; HIPPOCAMPAL CA3 REGION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEOCORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; REAL TIME POLYMERASE CHAIN REACTION; SUBICULUM; TEMPORAL CORTEX; VERY ELDERLY; WESTERN BLOTTING; WHITE MATTER; BIOSYNTHESIS; BRAIN; COHORT ANALYSIS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY;

AGED; AGED, 80 AND OVER; BRAIN; COHORT STUDIES; DEMENTIA, VASCULAR; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LEWY BODY DISEASE; MALE; MINOR HISTOCOMPATIBILITY ANTIGENS; PREGNANCY PROTEINS; TRANSAMINASES;

EID: 84961119503     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-016-1855-7     Document Type: Article

References (56)

1. Alzheimer’s Association (2015) Alzheimer’s disease facts and figures. Alzheimers Dement 11(3):332–384
2. Merz PA, Wisniewski HM, Somerville RA, Bobin SA, Masters CL, Iqbal K (1983) Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol 60(1–2):113–124
3. Braak H, Braak E, Bohl J (1993) Staging of Alzheimer-related cortical destruction. Eur Neurol 33(6):403–408
4. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65(1):1–105
5. Amaral MD, Pozzo-Miller L (2009) The dynamics of excitatory synapse formation on dendritic spines. Cell Sci 5(4):19–25
6. Riedel G, Platt B, Micheau J (2003) Glutamate receptor function in learning and memory. Behav Brain Res 140(1–2):1–47
7. Zhang Y, Bhavnani BR (2006) Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. BMC Neurosci 7:49
8. Stone TW, Addae JI (2002) The pharmacological manipulation of glutamate receptors and neuroprotection. Eur J Pharmacol 447(2–3):285–296. Review. Hall TR, Wallin R, Reinhart GD
9. Francis PT (2003) Glutamatergic systems in Alzheimer’s disease. Int J Geriatr Psychiatry. 18(Suppl 1):S15–S21
10. Francis PT (2009) Altered glutamate neurotransmission and behaviour in dementia: evidence from studies of memantine. Curr Mol Pharmacol 2(1):77–82
11. Procter AW, Palmer AM, Francis PT, Lowe SL, Neary D, Murphy E, Doshi R, Bowen DM (1988) Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer’s disease. J Neurochem 50(3):790–802
12. Penney JB, Maragos WF, Greenamyre JT, Debowey DL, Hollingsworth Z, Young AB (1990) Excitatory amino acid binding sites in the hippocampal region of Alzheimer’s disease and other dementias. J Neurol Neurosurg Psychiatry 53(4):314–320
13. Hull J, Patel VB, Hutson SM, Conway ME (2015) New insights into the role of the branched-chain aminotransferase proteins in the human brain. J Neurosci Res 93(7):987–998
14. Hull J, Patel V, El Hindy M, Lee C, Odeleye E, Hezwani M, Love S, Kehoe P, Chalmers K, Conway M (2015) Regional increase in the expression of the BCAT proteins in Alzheimer’s disease brain: implications in glutamate toxicity. J Alzheimers Dis 45(3):891–905
15. Ichihara A (1975) Isozyme patterns of branched-chain amino acid transaminase during cellular differentiation and carcinogenesis. Ann N Y Acad Sci 259:347–354
16. Davoodi J, Drown PM, Bledsoe RK, Wallin R, Reinhart GD, Hutson SM (1998) Overexpression and characterization of the human mitochondrial and cytosolic branched-chain aminotransferases. J Biol Chem 273(9):4982–4989
17. Sweatt AJ, Garcia-Espinosa MA, Wallin R, Hutson SM (2004) Branched-chain amino acids and neurotransmitter metabolism: expression of cytosolic branched-chain aminotransferase (BCATc) in the cerebellum and hippocampus. J Comp Neurol 477(4):360–370
18. Hull J, Hindy ME, Kehoe PG, Chalmers K, Love S, Conway ME (2012) Distribution of the branched chain aminotransferase proteins in the human brain and their role in glutamate regulation. J Neurochem 123(6):997–1009
19. Hutson SM, Lieth E, LaNoue KF (2001) Function of leucine in excitatory neurotransmitter metabolism in the central nervous system. J Nutr 131(3):846S–850S
20. LaNoue KF, Berkich DA, Conway M, Barber AJ, Hu LY, Taylor C, Hutson S (2001) Role of specific aminotransferases in de novo glutamate synthesis and redox shuttling in the retina. J Neurosci Res 66(5):914–922
21. Lieth E, LaNoue KF, Berkich DA et al (2001) Nitrogen shuttling between neurons and glial cells during glutamate synthesis. J Neurochem 76(6):1712–1723
22. Neef D, Walling AD (2006) Dementia with Lewy bodies: an emerging disease. Am Fam Physician 73(7):1223–1229
23. Jellinger KA (2009) Formation and development of Lewy pathology: a critical update. J Neurol 256(Suppl 3):270–279
24. Martin-Ruiz C, Lawrence S, Piggott M, Kuryatov A, Lindstrom J, Gotti C, Cookson MR, Perry RH, Jaros E, Perry EK, Court JA (2002) Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson’s disease: relation to changes in alpha-synuclein expression. Neurosci Lett. 335(2):134–138
25. O’Brien JT, Colloby SJ, Pakrasi S, Perry EK, Pimlott SL, Wyper DJ, McKeith IG, Williams ED (2008) Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes andvisual hallucinations. Neuroimage 40(3):1056–1063
26. Colloby SJ, Perry EK, Pakrasi S, Pimlott SL, Wyper DJ, McKeith IG, Williams ED, O’Brien JT (2010) Nicotinic 123I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in Alzheimer’s disease and dementia with Lewy bodies. Am J Geriatr Psychiatry 18(1):86–90
27. Albasanz JL, Dalfó E, Ferrer I, Martín M (2005) Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer’s disease and dementia with Lewy bodies correlates with stage of Alzheimer’s-disease-related changes. Neurobiol Dis 20(3):685–693
28. Bruno V, Battaglia G, Copani A, D’Onofrio M, Di Iorio P, De Blasi A, Melchiorri D, Flor PJ, Nicoletti F (2001) Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab 21(9):1013–1033
29. Jellinger KA (2007) The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol 113(4):349–388
30. Baskys A, Hou AC (2007) Vascular dementia: pharmacological treatment approaches and perspectives. Clin Interv Aging 2(3):327–335
31. Grinberg LT, Heinsen H (2010) Toward a pathological definition of vascular dementia. J Neurol Sci 299(1–2):136–138
32. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology. 41(4):479–486
33. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402–408
34. Daikhin Y, Yudkoff M (2000) Compartmentation of brain glutamate metabolism in neurons and glia. J Nutr 130(4S Suppl):1026S–1031S
35. Yudkoff M (1997) Brain metabolism of branched-chain amino acids. Glia 21(1):92–98
36. McKenna MC (2007) The glutamate-glutamine cycle is not stoichiometric: fates of glutamate in brain. J Neurosci Res 85(15):3347–3358
37. McKenna MC, Sonnewald U, Huang X, Stevenson J, Zielke HR (1996) Exogenous glutamate concentration regulates the metabolic fate of glutamate in astrocytes. J Neurochem 66(1):386–393
38. Brand K (1981) Metabolism of 2-oxoacid analogues of leucine, valine and phenylalanine by heart muscle, brain and kidney of the rat. Biochim Biophys Acta 677(1):126–132
39. Brand K, Hauschildt S (1984) Metabolism of 2-oxo-acid analogues of leucine and valine in isolated rat hepatocytes. Hoppe Seylers Z Physiol Chem 365(4):463–468
40. Sakai R, Cohen DM, Henry JF, Burrin DG, Reeds PJ (2004) Leucine-nitrogen metabolism in the brain of conscious rats: its role as a nitrogen carrier in glutamate synthesis in glial and neuronal metabolic compartments. J Neurochem 88(3):612–622
41. Roberts RC, Roche JK, McCullumsmith RE (2014) Localization of excitatory amino acid transporters EAAT1 and EAAT2 in human postmortem cortex: a light and electronmicroscopic study. Neuroscience 277:522–540
42. Kulijewicz-Nawrot M, Syková E, Chvátal A, Verkhratsky A, Rodríguez JJ (2013) Astrocytes and glutamate homoeostasis in Alzheimer’s disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex. ASN Neurol 5(4):273–282
43. Oldendorf WH, Cornford ME, Brown WJ (1977) The large apparent work capability of theblood-brain barrier: a study of the mitochondrial content of capillaryendothelial cells in brain and other tissues of the rat. Ann Neurol 1(5):409–417
44. Zerangue N, Kavanaugh MP (1996) Flux coupling in a neuronal glutamate transporter. Nature 383(6601):634–637
45. Rose EM, Koo JC, Antflick JE, Ahmed SM, Angers S, Hampson DR (2009) Glutamate transporter coupling to Na,K-ATPase. J Neurosci 29(25):8143–8155
46. Boyko M, Gruenbaum SE, Gruenbaum BF, Shapira Y, Zlotnik A (2014) Brain to blood glutamate scavenging as a novel therapeutic modality: a review. J Neural Transm (Vienna) 121(8):971–979
47. Dickstein DL, Walsh J, Brautigam H, Stockton SD Jr, Gandy S, Hof PR (2010) Role of vascular risk factors and vascular dysfunction in Alzheimer’s disease. Mt Sinai J Med 77(1):82–102
48. Lee J, Giordano S, Zhang J (2012) Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J 441(2):523–540
49. Lionaki E, Markaki M, Palikaras K, Tavernarakis N (2015) Mitochondria, autophagy and age-associated neurodegenerative diseases: New insights into a complex interplay. Biochim Biophys Acta 1847(11):1412–1423
50. Conway ME, Yennawar N, Wallin R, Poole LB, Hutson SM (2003) Human mitochondrial branched chain aminotransferase: structural basis for substrate specificity and role of redox active cysteines. Biochim Biophys Acta. 1647(1–2):61–65
51. Coles SJ, Easton P, Sharrod H, Hutson SM, Hancock J, Patel VB, Conway ME (2009) S-Nitrosoglutathione inactivation of the mitochondrial and cytosolic BCAT proteins: S-nitrosation and S-thiolation. Biochemistry 48(3):645–656
52. Conway ME, Coles SJ, Islam MM, Hutson SM (2008) Regulatory control of human cytosolic branched-chain aminotransferase by oxidation and S-glutathionylation and its interactions with redox sensitive neuronal proteins. Biochemistry 47(19):5465–5479
53. Gallogly MM, Mieyal JJ (2007) Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr Opin Pharmacol 7(4):381–391
54. Cederberg HH, Uhd NC, Brodin B (2014) Glutamate efflux at the blood-brain barrier: cellular mechanisms and potential clinical relevance. Arch Med Res 45(8):639–645
55. Gunnersen D, Haley B (1992) Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: a potential diagnostic biochemical marker. Proc Natl Acad Sci USA 89(24):11949–11953
56. Tumani H, Shen G, Peter JB, Brück W (1999) Glutamine synthetase in cerebrospinal fluid, serum, and brain: A diagnostic marker for Alzheimer disease? Arch Neurol 56(10):1241–1246